IPOBLSM
What to Watch as BlossomHill Therapeutics Prices Its NASDAQ IPO
BlossomHill Therapeutics, Inc. (NASDAQ: BLSM) is expected to list on 2026-08-07 at a price range of $15.00 to $17.00 per share. The company is offering 7,812,500 shares, implying a market cap of $152,734,375 if priced at the midpoint assumptions provided. The bull case is a focused oncology pipeline with named clinical programs and a seasoned drug-discovery team. The bear case is straightforward: no product revenue, rising losses, and a going-concern warning if it cannot raise more capital.
Aug 4, 20265 MIN